Jihye Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jihye Lim has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Dae Ryong Kang
Department of Precision Medicine & Biostatistics, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
5 shared publications - Doo Sup Kim
Department of Orthopedic Surgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Republic of Korea
3 shared publications - Young Un Choi
Department of Surgery, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea
3 shared publications - Hongjin Shim
Department of Surgery, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea
2 shared publications - Jae Hun Han
Department of Biostatistics, Yonsei University Wonju College of Medicine, Wonju, Korea
2 shared publications - Ji Wool Ko
Department of Surgery, Yonsei University Wonju College of Medicine, Wonju 26426, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 25 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (15) , 4360
Impact of High Risk of Obstructive Sleep Apnea on Health-Related Quality of Life: The Korean National Health and Nutrition Survey 2019–2021
Background/Objectives: Obstructive sleep apnea (OSA) impairs quality of life (QoL). However, its disease burden in the general population remains unknown. We aimed to investigate the association between OSA and health-related QoL in the general Korean population. Methods: This study analyzed cross-sectional datasets of adults (≥40 years) in the Korean National Health and Nutrition Examination Survey 2019–2021. QoL was assessed using the 3-level EuroQoL 5-dimension component (EQ-5D-3L). The high risk of OSA was determined using the STOP-Bang questionnaire (score ≥ 3). Demographic and clinical factors were included in linear regression analyses to identify the factors associated with EQ-5D-3L. Results: Of the 8966 total participants, 6792 (75.8%) and 2174 (24.2%) were classified as having a low risk and high risk of OSA, respectively. The high risk OSA group showed significantly lower QoL scores when compared with the low risk OSA group (0.939 ± 0.003 vs. 0.951 ± 0.002, p < 0.001). However, the mean difference was within the minimal clinically important difference (MCID) of EQ-5D-3L. Only females exceeded the MCID for the EQ-5D-3L. Elderly females with a high risk of OSA showed the lowest QoL. The regression coefficient of high risk OSA in the multivariate model was −0.018 (95% CI: −0.025–−0.01, p < 0.001). Patient demographics and comorbidities also showed significant associations with the EQ-5D-3L. Their regression coefficient was higher than that of high risk OSA. Conclusions: The impact of high risk OSA on QoL manifested differently according to age and sex. The impact of comorbidities on QoL was greater than that of high risk OSA, highlighting the important role of comorbidities and the need for their adjustment in the assessment of QoL.
- 25 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (15) , 4360
Open AccessImpact of High Risk of Obstructive Sleep Apnea on Health-Related Quality of Life: The Korean National Health and Nutrition Survey 2019–2021
Background/Objectives: Obstructive sleep apnea (OSA) impairs quality of life (QoL). However, its disease burden in the general population remains unknown. We aimed to investigate the association between OSA and health-related QoL in the general Korean population. Methods: This study analyzed cross-sectional datasets of adults (≥40 years) in the Korean National Health and Nutrition Examination Survey 2019–2021. QoL was assessed using the 3-level EuroQoL 5-dimension component (EQ-5D-3L). The high risk of OSA was determined using the STOP-Bang questionnaire (score ≥ 3). Demographic and clinical factors were included in linear regression analyses to identify the factors associated with EQ-5D-3L. Results: Of the 8966 total participants, 6792 (75.8%) and 2174 (24.2%) were classified as having a low risk and high risk of OSA, respectively. The high risk OSA group showed significantly lower QoL scores when compared with the low risk OSA group (0.939 ± 0.003 vs. 0.951 ± 0.002, p < 0.001). However, the mean difference was within the minimal clinically important difference (MCID) of EQ-5D-3L. Only females exceeded the MCID for the EQ-5D-3L. Elderly females with a high risk of OSA showed the lowest QoL. The regression coefficient of high risk OSA in the multivariate model was −0.018 (95% CI: −0.025–−0.01, p < 0.001). Patient demographics and comorbidities also showed significant associations with the EQ-5D-3L. Their regression coefficient was higher than that of high risk OSA. Conclusions: The impact of high risk OSA on QoL manifested differently according to age and sex. The impact of comorbidities on QoL was greater than that of high risk OSA, highlighting the important role of comorbidities and the need for their adjustment in the assessment of QoL.
- Open Access
- 16 May 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (5) , 532
The Association of Serum Uric Acid with Risk of Obstructive Sleep Apnea: The Korean National Health and Nutrition Examination Survey 2019–2021
Upper airway collapse and apneas in obstructive sleep apnea (OSA) induce intermittent hypercapnia and hypoxia, eventually contributing to excessive uric acid production. This study aimed to evaluate the association between hyperuricemia and OSA in the general population via analysis of the eighth KNHANES dataset (2019–2021). OSA risk was identified via the STOP-Bang questionnaire, with a score ≥3 indicating high risk. Among 11,981 total participants, 4572 (38.2%) had a high OSA risk. Participants with a high OSA risk had higher uric acid levels compared to those with a low risk (5.5 ± 1.4 mg/dL vs. 4.8 ± 1.2 mg/dL, p < 0.001). Serum uric acid levels were positively correlated with STOP-Bang score (r: 0.317, p < 0.001). Multivariate analysis revealed that hyperuricemia was associated with a high OSA risk after adjusting for confounders (odds ratio: 1.30, 95%CI: 1.11–1.53, p = 0.001). Therefore, serum uric acid levels are significantly higher in those with a high OSA risk and correlate with the risk of OSA. Further, hyperuricemia is an independently associated risk factor for high OSA risk. More research is warranted to evaluate the long-term clinical outcomes of hyperuricemia in OSA and to determine whether treatment targeting hyperuricemia is effective in the clinical course of OSA.
- 16 May 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (5) , 532
Open AccessThe Association of Serum Uric Acid with Risk of Obstructive Sleep Apnea: The Korean National Health and Nutrition Examination Survey 2019–2021
Upper airway collapse and apneas in obstructive sleep apnea (OSA) induce intermittent hypercapnia and hypoxia, eventually contributing to excessive uric acid production. This study aimed to evaluate the association between hyperuricemia and OSA in the general population via analysis of the eighth KNHANES dataset (2019–2021). OSA risk was identified via the STOP-Bang questionnaire, with a score ≥3 indicating high risk. Among 11,981 total participants, 4572 (38.2%) had a high OSA risk. Participants with a high OSA risk had higher uric acid levels compared to those with a low risk (5.5 ± 1.4 mg/dL vs. 4.8 ± 1.2 mg/dL, p < 0.001). Serum uric acid levels were positively correlated with STOP-Bang score (r: 0.317, p < 0.001). Multivariate analysis revealed that hyperuricemia was associated with a high OSA risk after adjusting for confounders (odds ratio: 1.30, 95%CI: 1.11–1.53, p = 0.001). Therefore, serum uric acid levels are significantly higher in those with a high OSA risk and correlate with the risk of OSA. Further, hyperuricemia is an independently associated risk factor for high OSA risk. More research is warranted to evaluate the long-term clinical outcomes of hyperuricemia in OSA and to determine whether treatment targeting hyperuricemia is effective in the clinical course of OSA.
- Open Access
- 2 January 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (1) , e9138
Hemodynamic Effect of Repeated Epinephrine Doses Decreases With Cardiopulmonary Resuscitation Cycle Progression
Background: Epinephrine is administered to increase coronary perfusion pressure during advanced life support and promote short‐term survival. Recent cardiopulmonary resuscitation (CPR) guidelines recommend an epinephrine dosing interval of 3 to 5 minutes during resuscitation; however, scientific evidence supporting this recommendation is lacking. Therefore, we aimed to investigate the hemodynamic effects of repeated epinephrine doses during CPR by monitoring augmented blood pressure after its administration in a swine model of cardiac arrest. Methods and Results: A secondary analysis of data from a published study was performed using a swine cardiac arrest model. The epinephrine dose was fixed at 1 mg, and the first dose of epinephrine was administered after no‐flow and low‐flow times of 2 minutes and 8 minutes, respectively, and subsequently administered every 4 minutes. Four cycles of dosing intervals were defined because a previous study was terminated 26 minutes after the induction of ventricular fibrillation. Augmented blood pressures and corresponding timelines were determined. Augmented blood pressure trends following cycles and the epinephrine effect duration were also monitored. Among the 140 CPR cycles, the augmented blood pressure after epinephrine administration was the highest during the first cycle of CPR and decreased gradually with further cycle repetitions. The epinephrine effect duration did not differ between repeated cycles. The maximum blood pressure was achieved 78 to 97 seconds after epinephrine administration. Conclusions: Hemodynamic augmentation with repeated epinephrine administration during CPR decreased with cycle progression. Further studies are required to develop an epinephrine administration strategy to maintain its hemodynamic effects during prolonged resuscitation.
- 2 January 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (1) , e9138
Open AccessHemodynamic Effect of Repeated Epinephrine Doses Decreases With Cardiopulmonary Resuscitation Cycle Progression
Background: Epinephrine is administered to increase coronary perfusion pressure during advanced life support and promote short‐term survival. Recent cardiopulmonary resuscitation (CPR) guidelines recommend an epinephrine dosing interval of 3 to 5 minutes during resuscitation; however, scientific evidence supporting this recommendation is lacking. Therefore, we aimed to investigate the hemodynamic effects of repeated epinephrine doses during CPR by monitoring augmented blood pressure after its administration in a swine model of cardiac arrest. Methods and Results: A secondary analysis of data from a published study was performed using a swine cardiac arrest model. The epinephrine dose was fixed at 1 mg, and the first dose of epinephrine was administered after no‐flow and low‐flow times of 2 minutes and 8 minutes, respectively, and subsequently administered every 4 minutes. Four cycles of dosing intervals were defined because a previous study was terminated 26 minutes after the induction of ventricular fibrillation. Augmented blood pressures and corresponding timelines were determined. Augmented blood pressure trends following cycles and the epinephrine effect duration were also monitored. Among the 140 CPR cycles, the augmented blood pressure after epinephrine administration was the highest during the first cycle of CPR and decreased gradually with further cycle repetitions. The epinephrine effect duration did not differ between repeated cycles. The maximum blood pressure was achieved 78 to 97 seconds after epinephrine administration. Conclusions: Hemodynamic augmentation with repeated epinephrine administration during CPR decreased with cycle progression. Further studies are required to develop an epinephrine administration strategy to maintain its hemodynamic effects during prolonged resuscitation.
- Open Access
- 1 January 2024
- Published by XMLink in Yonsei Medical Journal
- Vol. 65 (12) , 761-769
Epidemiologic Trends and Socioeconomic Disparities of Ankylosing Spondylitis in South Korea: A Nationwide Population-Based Study, 2010–2021
Nam SW, et al. Yonsei Med J. 2024 Sep;65:e66. https://doi.org/10.3349/ymj.2024.0041
- 1 January 2024
- Published by XMLink in Yonsei Medical Journal
- Vol. 65 (12) , 761-769
Open AccessEpidemiologic Trends and Socioeconomic Disparities of Ankylosing Spondylitis in South Korea: A Nationwide Population-Based Study, 2010–2021
Nam SW, et al. Yonsei Med J. 2024 Sep;65:e66. https://doi.org/10.3349/ymj.2024.0041
- Open Access
- 31 December 2023
- Published by Korean Society of Clinical Toxicology in Journal of the Korean society of clinical toxicology
- Vol. 21 (2) , 117-127
Comparison of hyperbaric oxygen therapy pressures for acute carbon monoxide poisoning
Purpose: No consensus currently exists regarding the maximal pressure of hyperbaric oxygen (HBO2) therapy performed within 24 hours of acute carbon monoxide (CO) poisoning. This study aimed to evaluate the difference in therapeutic effects according to the first HBO2 pressure (3.0 atmospheres absolute [ATA] vs. 2.8 ATA).Methods: We used prospectively collected registry data on CO poisoning at a tertiary academic hospital in the Republic of Korea. Adult patients with acute CO poisoning treated with HBO2 within 24 hours after arrival at the emergency department and without the use of additional HBO2 after 24 hours between January 2007 and February 2022 were included. Data from 595 patients were analyzed using propensity score matching (PSM). Patients with mild (non-intubated) and severe (intubated) poisoning were also compared. Neurocognitive outcomes at 1 month after CO poisoning were evaluated using the Global Deterioration Scale combined with neurological impairment.Results: After PSM, the neurocognitive outcomes at 1-month post-CO exposure were not significantly different between the 2.8 ATA (110 patients) and 3.0 ATA (55 patients) groups (p=1.000). Similarly, there was also no significant difference in outcomes in a subgroup analysis according to poisoning severity in matched patients (165 patients) (mild [non-intubated]: p=0.053; severe [intubated]: p=1.000).Conclusion: Neurocognitive sequelae at 1 month were not significantly different between HBO2 therapy pressures of 2.8 ATA and 3.0 ATA in patients with acute CO poisoning. In addition, the 1-month neurocognitive sequelae did not differ significantly between intubated and non-intubated patients.
- 31 December 2023
- Published by Korean Society of Clinical Toxicology in Journal of the Korean society of clinical toxicology
- Vol. 21 (2) , 117-127
Open AccessComparison of hyperbaric oxygen therapy pressures for acute carbon monoxide poisoning
Purpose: No consensus currently exists regarding the maximal pressure of hyperbaric oxygen (HBO2) therapy performed within 24 hours of acute carbon monoxide (CO) poisoning. This study aimed to evaluate the difference in therapeutic effects according to the first HBO2 pressure (3.0 atmospheres absolute [ATA] vs. 2.8 ATA).Methods: We used prospectively collected registry data on CO poisoning at a tertiary academic hospital in the Republic of Korea. Adult patients with acute CO poisoning treated with HBO2 within 24 hours after arrival at the emergency department and without the use of additional HBO2 after 24 hours between January 2007 and February 2022 were included. Data from 595 patients were analyzed using propensity score matching (PSM). Patients with mild (non-intubated) and severe (intubated) poisoning were also compared. Neurocognitive outcomes at 1 month after CO poisoning were evaluated using the Global Deterioration Scale combined with neurological impairment.Results: After PSM, the neurocognitive outcomes at 1-month post-CO exposure were not significantly different between the 2.8 ATA (110 patients) and 3.0 ATA (55 patients) groups (p=1.000). Similarly, there was also no significant difference in outcomes in a subgroup analysis according to poisoning severity in matched patients (165 patients) (mild [non-intubated]: p=0.053; severe [intubated]: p=1.000).Conclusion: Neurocognitive sequelae at 1 month were not significantly different between HBO2 therapy pressures of 2.8 ATA and 3.0 ATA in patients with acute CO poisoning. In addition, the 1-month neurocognitive sequelae did not differ significantly between intubated and non-intubated patients.
- Open Access
- 27 December 2023
- Published by MDPI AG in Diagnostics
- Vol. 14 (1) , 60
Clinical and Echocardiographic Predictors for the Presence of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Patients with Carbon Monoxide Poisoning
Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMRI) reflects the burden of myocardial damage in carbon monoxide (CO) poisoning. This study aimed to identify the clinical and echocardiographic parameters that can predict myocardial LGE on CMRI in CO poisoning. This prospective observational study included patients who presented with acute CO poisoning and elevated troponin I and underwent echocardiography and CMRI to identify myocardial damage at a tertiary university hospital between August 2017 and May 2019 and August 2020 and July 2022. Based on the CMRI findings, participants were categorized into LGE and non-LGE groups. The median age of the 155 patients was 51.0 years, and 98 (63.2%) were males. Median times from emergency department arrival to either CMRI or echocardiography were 3.0 days each. The LGE group included 99 (63.9%) patients with LGE positivity on CMRIs. Time from rescue to hyperbaric oxygen therapy >4 h (odds ratio (OR): 3.31, 95% confidence interval (CI): 1.28–8.56, p = 0.01); serum lactate levels >2 mmol/L (OR: 2.62, 95% CI: 1.20–5.73, p = 0.02); and left ventricular global longitudinal strain >−16% (OR: 2.95, 95% CI: 1.35–6.47, p = 0.007) were significant predictors of LGE positivity. The area under the curve of these predictors was 0.711. Our prediction model, which combines the clinical parameters with left ventricular global longitudinal strain, may be helpful in the early detection of LGE positivity.
- 27 December 2023
- Published by MDPI AG in Diagnostics
- Vol. 14 (1) , 60
Open AccessClinical and Echocardiographic Predictors for the Presence of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Patients with Carbon Monoxide Poisoning
Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMRI) reflects the burden of myocardial damage in carbon monoxide (CO) poisoning. This study aimed to identify the clinical and echocardiographic parameters that can predict myocardial LGE on CMRI in CO poisoning. This prospective observational study included patients who presented with acute CO poisoning and elevated troponin I and underwent echocardiography and CMRI to identify myocardial damage at a tertiary university hospital between August 2017 and May 2019 and August 2020 and July 2022. Based on the CMRI findings, participants were categorized into LGE and non-LGE groups. The median age of the 155 patients was 51.0 years, and 98 (63.2%) were males. Median times from emergency department arrival to either CMRI or echocardiography were 3.0 days each. The LGE group included 99 (63.9%) patients with LGE positivity on CMRIs. Time from rescue to hyperbaric oxygen therapy >4 h (odds ratio (OR): 3.31, 95% confidence interval (CI): 1.28–8.56, p = 0.01); serum lactate levels >2 mmol/L (OR: 2.62, 95% CI: 1.20–5.73, p = 0.02); and left ventricular global longitudinal strain >−16% (OR: 2.95, 95% CI: 1.35–6.47, p = 0.007) were significant predictors of LGE positivity. The area under the curve of these predictors was 0.711. Our prediction model, which combines the clinical parameters with left ventricular global longitudinal strain, may be helpful in the early detection of LGE positivity.
- Open Access
- 30 November 2023
- Published by The Korean Society of Health Informatics and Statistics in Journal of Health Informatics and Statistics
- Vol. 48 (Suppl 2) , S23-S33
Statistical Methods for Visualizing Healthcare Big Data
With the advancement and acceleration of digital technology, the demand and supply of healthcare big data are increasing. In Korea, the government and companies have made various efforts to utilize healthcare big data, such as deregulation data-related legal regulations and data linkage between different institutions. As a result, many researchers have been able to access a variety of healthcare big data. Although healthcare big data has a vast amount and high value, many researchers are unable to fully access healthcare big data because there are difficulties in processing, analysis, and interpretation for data. The data visualization is recognized as an important tool that can solve these limitations. Using data visualization, researchers can intuitively understand complex data and receive support for decision-making. Additionally, these visualizations promote effective communication between experts in different fields and between experts and non-experts. Visualization is used in a variety of research fields and processes, including data summarization, data exploration, and evaluation and interpretation of predictive models. Various types of visualization have different meanings depending on how they are expressed. Therefore, it is important to express the meaning of visualization appropriately. This study provides representative examples of visual representations for data summarization, data exploration, and predictive model evaluation. This study aimed to improve easier access and utilization of healthcare big data by providing R code and visualization results.
- 30 November 2023
- Published by The Korean Society of Health Informatics and Statistics in Journal of Health Informatics and Statistics
- Vol. 48 (Suppl 2) , S23-S33
Open AccessStatistical Methods for Visualizing Healthcare Big Data
With the advancement and acceleration of digital technology, the demand and supply of healthcare big data are increasing. In Korea, the government and companies have made various efforts to utilize healthcare big data, such as deregulation data-related legal regulations and data linkage between different institutions. As a result, many researchers have been able to access a variety of healthcare big data. Although healthcare big data has a vast amount and high value, many researchers are unable to fully access healthcare big data because there are difficulties in processing, analysis, and interpretation for data. The data visualization is recognized as an important tool that can solve these limitations. Using data visualization, researchers can intuitively understand complex data and receive support for decision-making. Additionally, these visualizations promote effective communication between experts in different fields and between experts and non-experts. Visualization is used in a variety of research fields and processes, including data summarization, data exploration, and evaluation and interpretation of predictive models. Various types of visualization have different meanings depending on how they are expressed. Therefore, it is important to express the meaning of visualization appropriately. This study provides representative examples of visual representations for data summarization, data exploration, and predictive model evaluation. This study aimed to improve easier access and utilization of healthcare big data by providing R code and visualization results.
- Open Access
- 30 November 2023
- Published by The Korean Society of Health Informatics and Statistics in Journal of Health Informatics and Statistics
- Vol. 48 (4) , 349-355
Health Examination Participation Rate and Disease Prevalence of Farmers: Using National Health Insurance Service Data
Objectives: This study aims to identify the major diseases among farmers through disease prevalence and proposes the necessity of essential disease management services tailored to the occupational characteristics prevalent among farmers.Methods: Using data from National Health Insurance Services (NHIS), individuals who were eligible for agricultural insurance premium reduction benefits were identified, and individuals meeting these criteria and those who did not were sampled in a 1:1 ratio. Subjects were defined as farmers and non-farmers by categorizing individuals who were classified as farmers for two consecutive years, 2018 and 2019, and those who were not. Age-standardized disease prevalence rates for 21 major disease categories were examined among farmers and non-farmers, and health examination participation rates were compared.Results: Farmers exhibited higher disease prevalence in categories such as ‘External causes of morbidity and mortality’, ‘Codes for special purposes’, and ‘Injury, poisoning, and certain other consequences of external causes’. Particularly in ‘External causes of morbidity and mortality’ and ‘Injury, poisoning and certain other consequences of external causes’ the differences between farmers and non-farmers were significantly pronounced. Additionally, the health examination participation rate among the farmers was notably lower compared to the general population.Conclusions: To enhance the health status of farmers, a multifaceted approach and policy support must be established to ensure that universal healthcare does not exclude them due to regional characteristics. The study anticipates that its findings will be foundational for expanding the pilot project targeting female farmers’ special health examinations, eventually encompassing all farmers.
- 30 November 2023
- Published by The Korean Society of Health Informatics and Statistics in Journal of Health Informatics and Statistics
- Vol. 48 (4) , 349-355
Open AccessHealth Examination Participation Rate and Disease Prevalence of Farmers: Using National Health Insurance Service Data
Objectives: This study aims to identify the major diseases among farmers through disease prevalence and proposes the necessity of essential disease management services tailored to the occupational characteristics prevalent among farmers.Methods: Using data from National Health Insurance Services (NHIS), individuals who were eligible for agricultural insurance premium reduction benefits were identified, and individuals meeting these criteria and those who did not were sampled in a 1:1 ratio. Subjects were defined as farmers and non-farmers by categorizing individuals who were classified as farmers for two consecutive years, 2018 and 2019, and those who were not. Age-standardized disease prevalence rates for 21 major disease categories were examined among farmers and non-farmers, and health examination participation rates were compared.Results: Farmers exhibited higher disease prevalence in categories such as ‘External causes of morbidity and mortality’, ‘Codes for special purposes’, and ‘Injury, poisoning, and certain other consequences of external causes’. Particularly in ‘External causes of morbidity and mortality’ and ‘Injury, poisoning and certain other consequences of external causes’ the differences between farmers and non-farmers were significantly pronounced. Additionally, the health examination participation rate among the farmers was notably lower compared to the general population.Conclusions: To enhance the health status of farmers, a multifaceted approach and policy support must be established to ensure that universal healthcare does not exclude them due to regional characteristics. The study anticipates that its findings will be foundational for expanding the pilot project targeting female farmers’ special health examinations, eventually encompassing all farmers.
- Open Access
- 17 September 2023
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2023 (1)
Environmental Exposure to Risk Factors and Its Effects on Heart Rate Variability in Vulnerable and Susceptible Individuals
- 17 September 2023
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2023 (1)
Open AccessEnvironmental Exposure to Risk Factors and Its Effects on Heart Rate Variability in Vulnerable and Susceptible Individuals
- Open Access
- 6 June 2023
- Published by Hindawi Limited in Emergency Medicine International
- Vol. 2023, 1-5
Association of Chest Anteroposterior Radiography with Computed Tomography in Patients with Blunt Chest Trauma
Background. In cases of chest trauma, computed tomography (CT) can be used alongside chest anteroposterior (AP) radiography and physical examination during initial evaluation. Performing a CT scan may be difficult if a patient has unstable vital signs. In contrast, radiography may not always reliably diagnose nonmarked pneumothorax or extensive subcutaneous emphysema. Objectives. This study aimed to determine the agreement between chest radiography and CT findings in patients with blunt chest trauma. The study also aimed to determine the occurrence of occult pneumothorax and clarify the proportion of subcutaneous emphysema and pneumothorax detected through radiography and CT, respectively. Methods. We included patients (n=1284) with chest trauma who were admitted to the emergency room of a tertiary hospital between January 2015 and June 2022. We excluded patients aged Results. Radiography exhibited a specificity of nearly 100 for all items. In most cases, findings that could not be confirmed by CT were not evident on radiographs. The incidence of occult pneumothorax was 87.3. When subcutaneous emphysema was observed on radiography, CT findings indicated pneumothorax in 96.7 of cases. Conclusions. In situations where the patients vital signs are unstable and performing a CT scan is not feasible, the presence of subcutaneous emphysema on radiography may indicate the need for chest decompression, even if pneumothorax is not observed.
- 6 June 2023
- Published by Hindawi Limited in Emergency Medicine International
- Vol. 2023, 1-5
Open AccessAssociation of Chest Anteroposterior Radiography with Computed Tomography in Patients with Blunt Chest Trauma
Background. In cases of chest trauma, computed tomography (CT) can be used alongside chest anteroposterior (AP) radiography and physical examination during initial evaluation. Performing a CT scan may be difficult if a patient has unstable vital signs. In contrast, radiography may not always reliably diagnose nonmarked pneumothorax or extensive subcutaneous emphysema. Objectives. This study aimed to determine the agreement between chest radiography and CT findings in patients with blunt chest trauma. The study also aimed to determine the occurrence of occult pneumothorax and clarify the proportion of subcutaneous emphysema and pneumothorax detected through radiography and CT, respectively. Methods. We included patients (n=1284) with chest trauma who were admitted to the emergency room of a tertiary hospital between January 2015 and June 2022. We excluded patients aged Results. Radiography exhibited a specificity of nearly 100 for all items. In most cases, findings that could not be confirmed by CT were not evident on radiographs. The incidence of occult pneumothorax was 87.3. When subcutaneous emphysema was observed on radiography, CT findings indicated pneumothorax in 96.7 of cases. Conclusions. In situations where the patients vital signs are unstable and performing a CT scan is not feasible, the presence of subcutaneous emphysema on radiography may indicate the need for chest decompression, even if pneumothorax is not observed.